SPPAM
ITCI
Summit Partners Public Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,515
| Closed | -$5.35M | – | 136 |
|
|
2023
Q2 | $5.35M | Buy |
84,515
+83,926
| +14,249% | +$5.31M | 0.2% | 58 |
|
|
2023
Q1 | $31.9K | Buy |
+589
| New | +$31.9K | ﹤0.01% | 66 |
|
|
2022
Q3 | – | Sell |
-138,331
| Closed | -$7.9M | – | 130 |
|
|
2022
Q2 | $7.9M | Sell |
138,331
-101,572
| -42% | -$5.8M | 0.36% | 43 |
|
|
2022
Q1 | $14.7M | Buy |
+239,903
| New | +$14.7M | 0.52% | 42 |
|